Q4 2026 Accuray Incorporated Earnings Call Transcript
Key Points
- Accuray Inc (ARAY) exceeded its transformation cost-saving target, realizing over $20 million in cost and margin improvements in fiscal 2026 versus a $12 million target.
- The company strengthened its financial position through a comprehensive transaction with TCW, including debt conversion, a $15 million cash investment, and a covenant holiday through December 2027.
- Service revenue grew 4% year-over-year to $229 million, driven by pricing actions and an expanding installed base, with service gross margins improving sequentially.
- The company is building a strategic partnership ecosystem, including a landmark 10-year collaboration with the University of Wisconsin to advance adaptive radiation therapy.
- Clinical data presented at ESTRO 2026 reinforced the differentiated capabilities of Accuray's CyberKnife and Radixact platforms, leading to a meaningful increase in qualified leads.
- Total revenue declined 12% year-over-year to $402 million, with product revenue down 27% due to a $58 million drop in China sales from geopolitical tensions and tariff uncertainty.
- Full-year gross margin fell to 27.7% from 32.1% in the prior year, impacted by higher non-EPA tariff expenses and unfavorable product mix.
- The company reported an operating loss of $26.4 million for fiscal 2026, compared to operating income of $7.8 million in the prior year.
- Adjusted EBITDA declined significantly to $10.6 million from $28.3 million in the prior year, reflecting lower product revenue and margin pressures.
- Management did not provide formal revenue or adjusted EBITDA guidance for fiscal 2027 due to ongoing geopolitical, tariff, and macroeconomic uncertainties, limiting visibility for investors.
Good day, and welcome to the Accuray fourth quarter fiscal 2026 financial results conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Mr. Steve Monroe, Vice President of Corporate Financial Planning and Analysis. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone. Welcome to Accuray's conference call to review financial results for the fourth quarter of fiscal year 2026, which ended June 30, 2026. During our call this afternoon, management will review recent corporate developments. Joining us on today's call are Steve LaNeve, Accuray's President and Chief Executive Officer; and Ali Pervaiz, Accuray's Chief Financial Officer.
Before we begin, I would like to remind everyone that our discussion today includes forward-looking statements. Actual results may differ materially from those contemplated or implied by these forward-looking statements. Factors
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
